Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Harvard Business School
Medtronic
QuintilesIMS
Cantor Fitzgerald
UBS

Generated: April 21, 2019

DrugPatentWatch Database Preview

Tentative Approvals for: doxepin hydrochloride

« Back to Dashboard

doxepin hydrochloride Drugs with Tentative Approvals

Applicant Generic Name NDA Strength Dosage Form
Par Pharm doxepin hydrochloride 202510 6MG TABLET; ORAL
Zydus Pharms Usa Inc doxepin hydrochloride 202761 6MG TABLET; ORAL
Par Pharm doxepin hydrochloride 202510 3MG TABLET; ORAL
Zydus Pharms Usa Inc doxepin hydrochloride 202761 3MG TABLET; ORAL
Applicant Generic Name NDA Strength Dosage Form

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Mallinckrodt
Daiichi Sankyo
Citi
Fish and Richardson
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.